Sleep Apnea Devices Market Size, Share & COVID-19 Impact Analysis, By Device Type (Therapeutic Devices, and Diagnostic Devices), By End User (Sleep Laboratories & Clinics, and Homecare & Other Settings), and Regional Forecast, 2021-2028

The global sleep apnea devices market size was USD 8.55 billion in 2020 and is projected to grow from USD 8.09 billion in 2021 to USD 13.10 billion in 2028, exhibiting a CAGR of 7.1% in the 2021-2028 period. Based on our analysis, the market exhibited a stellar growth of 9.4% in 2020 as compared to the average year-on-year growth during 2017-2019. The impact of COVID-19 has been unprecedented and staggering, with the devices witnessing a positive impact on demand globally amid the pandemic. The fall in CAGR is attributable to this market’s demand and growth, returning to pre-pandemic levels once the pandemic is over.

Sleep apnea is referred to as a sleeping disorder that can be potentially serious, wherein the breathing of an individual demonstrates an abnormal pattern. People with untreated sleep apnea experience interrupted breathing in their sleep due to lack of oxygen supply to the brain and the rest of the body parts. This condition is more common among elderly patients and people suffering from diseases like diabetes, hypertension, cardiovascular disorders, and others. Globally, obstructive sleep apnea (OSA) is the most prevalent type of sleep apnea, and to prevent this, early diagnosis and use of therapeutic devices are essential.

For instance, according to the data published by Lancet, approximately 1 billion people across the world were suffering from sleep apnea in 2019. Thus, the globally increasing incidence of such disorder coupled with rising geriatric population and associated comorbidities is expected to fuel the demand for treatment and subsequently drive the market growth during the forecast period. Also, the COVID-19 global pandemic has presented unprecedented challenges to market growth in 2020.

COVID-19 Pandemic to Positively Impact the Growth of the Global Market

The outbreak of the COVID-19 pandemic has positively impacted the global market. Key players reported a significant growth in the revenue from due to increase in the number of patients suffering from sleep disorders due to excessive stress resulting from the COVID-19 pandemic. For instance, after the onset of COVID-19, Philips surveyed 1,300 adults in 13 countries to capture attitudes, perceptions, and behaviors around sleep. The survey revealed since the beginning of the COVID-19, 70% of the respondents experienced one or more new sleep challenges, thus leading to increasing use of sleep apnea devices.

Also, attributable to this, the company introduced a clinically validated, low-touch CPAP Mask Selector tool that can be used remotely from the comfort of the patient’s home. Moreover, Fisher & Paykel Healthcare Limited, one of the key players in the sleep apnea market, witnessed revenue growth of 9% in their “homecare product” segment, including products for the treatment of obstructive sleep apnea (OSA).

LATEST TRENDS

Introduction of Advanced Devices for Sleep Apnea Management to Fuel the Sleep Apnea Devices Market Growth

The shift of patients toward technologically advanced devices has been pivotal in developing new alternatives for sleep apnea management. For instance, the adoption of oral devices such as the mandibular advancement device (MAD) for OSA treatment has increased due to the discomfort caused by CPAP devices in patients. Also, according to the data published by NCBI based on various studies conducted in different countries, it is estimated that the compliance rate for CPAP devices among users has declined by up to 50.0%, and this has led to the launch of alternatives like oral appliances in the market that have proved to be effective and offer comfort to patients during the treatment of the disorder.

Along with this, actometer, a portable diagnostic device, has gained huge popularity among sleep clinics due to its non-invasive nature and low cost compared to traditional polysomnography devices (PSG). Hence, increasing non-adherence for CPAP devices coupled with the high demand for cost-effective diagnostic devices is propelling the shift of patients towards oral appliances and actometers for effective management of sleep apnea.

DRIVING FACTORS

Growing Prevalence of Obstructive Sleep Apnea to Spur Demand for Devices

According to the data published by Sleep Science Resource, LLC., it is estimated that 1 in 15 adults in the U.S. suffers from obstructive sleep apnea (OSA), which equals 18 million people. The sedentary lifestyle of people has led to an increasing prevalence of cardiovascular diseases, poor sleep patterns, elevated stress, and obesity.

For instance, according to the article published by American Heart Association, Inc., several cross-sectional studies have estimated that significant sleep apnea is present in 40% of the obese population, and 70% of the OSA patients are obese. Also, according to the data published by the European Respiratory Society, approximately 13.0% to 32.0% of the geriatric population in Europe was suffering from sleep apnea.

Rising prevalence of obesity and other lifestyle disorders, and increasing diagnosis rates for sleep apnea in developed and developing countries is presenting a large patient pool requiring treatment or management of the condition. This combined with increasing number of sleep clinics, and sleep technicians globally is facilitating the growth of the market. Also there is a large pool of undiagnosed patients especially in developing countries. Various organizations and government agencies are focusing on increasing the awareness and diagnosis rates among these patients, through various campaigns such as ‘sleep awareness week’. This is further anticipated to drive the growth of the market during the forecast period. 

RESTRAINING FACTORS

High Cost of Devices to Restrict the Growth of the Market

Despite the increasing prevalence of the disorder and sedentary lifestyle-related conditions globally, certain factors are restricting the growth of the market. Among them is the high cost associated with devices.

The CPAP and PSG sleep apnea devices are the preferred choices for OSA management. A CPAP machine costs around USD 600 to USD 800 in the U.S., which makes it significantly cost intensive without medical insurance. Developed countries have a well-established infrastructure and reimbursement system in place. However, developing countries have a lackluster reimbursement system, and a significant out of pocket costs for patients. This is along with limited penetration of medical coverage in these countries which is further limiting the number of patients undergoing treatment in these countries. This is restraining the growth of the market.

SEGMENTATION

By Device Type Analysis

Therapeutic Devices to Dominate during the Forecast Period

In terms of device type, the market is segmented into therapeutic devices and diagnostic devices. The therapeutic device segment dominated the market in 2020. Increasing number of diagnosed patients undergoing treatment in sleep clinics including CPAP therapy, especially in developed countries, is responsible for dominance of the therapeutic segment in 2020. According to KOL interviews, around 95% of the diagnosed population in the U.S. undergo treatment, and CPAP is the most preferred mode of treatment among these patients.

Presence of large undiagnosed population and growing awareness among these patients are leading to higher diagnosis rates in developed and developing countries. This is creating demand for diagnostic devices, such as polysomnography devices, in these countries.

By End User Analysis

Homecare & Other Settings Dominated the Global Market in 2020

Based on end-user, the market is segmented into homecare & other settings and sleep laboratories & clinics. Market players are focusing on introducing new and portable devices for home use among patients undergoing treatment for the condition. This along with increasing shift of preference towards home settings for treatment of OSA, especially in countries such as U.S., U.K., Germany, and Japan, among others, is leading to higher demand for these devices by homecare and other settings.

For instance, in February 2021, GoPAPfree, a homecare provider of oral appliance therapy for sleep apnea, launched O2Vent OptimaI, which is a highly effective and alternative therapy to CPAP therapy that can be used at one’s home. This combined with adequate reimbursement policies being implemented, which facilitate the home use of these devices is further facilitating the market growth.

Increasing number of sleep clinics, and sleep technicians in the developed and developing countries, is leading to rising flow of patients towards these sleep clinics. This along with adequate reimbursement policies in these settings is driving the growth of the segment.

REGIONAL INSIGHTS

The market size in North America stood at USD 4.16 billion in 2020. The dominance of North America is attributable to the higher prevalence of the disorder and favorable reimbursement policies, which have been pivotal in the higher adoption of such devices in the region. According to the American Academy of Sleep Medicine (AASM), about 3.0%-7.0% of men and 2.0%-5.0% of women have sleep apnea in the U.S.

On the other hand, the market in Europe is expected to grow at a significant CAGR by 2028, owing to rising awareness about sleep apnea and increasing demand for diagnostic tests coupled with high adoption of these devices in this region.

The market of Asia Pacific is anticipated to grow faster due to increasing demand for sleep apnea devices in Japan and Australia and the growing prevalence of sleep apnea in emerging countries. According to studies published, an estimated 14% adult population in India was suffering from sleep apnea.

Latin America and the Middle East & Africa are expected to grow at a moderate CAGR due to lack of awareness among the general population about sleep apnea and huge underpenetrated markets in both of these regions.

KEY INDUSTRY PLAYERS

Koninklijke Philips N.V. and ResMed Held a Dominant Share of the Market in 2020

The market is extremely competitive and includes major players such as Koninklijke Philips N.V. and ResMed. The strong and diverse portfolio of these players, their focus on R&D to introduce sleep apnea devices, and strong geographical presence are some of the factors primarily attributed to the dominance of these players in the global market. For instance, in October 2021, ResMed launched the next generation PAP device to treat OSA. Thus, increasing advancements and innovations by market players is expected to increase the adoption of these devices during the forecast period.

Other key players engaged in the market are Oventus, Cadwell Industries, Inc., Fisher & Paykel Healthcare Limited., Natus Medical Incorporated, SomnoMed, DeVilbiss Healthcare LLC, and Braebon Medical Corporation.

LIST OF KEY COMPANIES PROFILED:

• Koninklijke Philips N.V. (Amsterdam, Netherlands)


• Oventus, Indooroopilly (Australia)


• Cadwell Industries, Inc. (Kennewick, U.S.)


• ResMed (San Diego, U.S.)


• Fisher & Paykel Healthcare Limited (Auckland, New Zealand)


• Natus Medical Incorporated (Pleasanton, U.S.)


• SomnoMed (Sydney, Australia)


• DeVilbiss Healthcare LLC (Pennsylvania, U.S.)


• Braebon Medical Corporation (Ontario, Canada)

KEY INDUSTRY DEVELOPMENTS:

• February 2021 – Signifier Medical Technologies received the USFDA approval for eXciteOSA (the first-ever daytime treatment), an intraoral neuromuscular stimulation device for treating OSA


• August 2021 – Vivos Therapeutics, Inc. and Empower Sleep entered into a cooperative relationship to significantly improve obstructive sleep apnea diagnosis and treatment.

REPORT COVERAGE

The global sleep apnea devices market research report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading applications of the product. Besides this, the report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over recent years.

Report Scope & Segmentation